Bilimsel çalışmalar

Doç. Dr. Mesut Tığlıoğlu

43 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. 2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group

    Clinical Lymphoma Myeloma and Leukemia, 2026

    DOI 10.1016/j.clml.2026.08.008 PMID 42705998 Kaynak: ORCID

  2. Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study

    Leukemia Research, 2026

    DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Kaynak: OpenAlex

  3. Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL

    Annals of Hematology, 2026

    DOI 10.1007/s00277-026-07201-y PMID 42897372 Açık erişimli tam metinKaynak: ORCID

  4. PA-211 Gastric Extramedullary Disease as the Initial Manifestation of IgA Kappa Multiple Myeloma with Rapid Fatal Progression

    Clinical Lymphoma Myeloma & Leukemia, 2026

    DOI 10.1016/s2152-2650(26)03578-0 Kaynak: OpenAlex

  5. SMOLDERING MULTIPLE MYELOMA, DIAGNOSIS AND MANAGEMENT

    Turkiye Klinikleri eBooks, 2025

    DOI 10.5336/978-625-395-694-3_p9 Kaynak: OpenAlex

  6. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia

    Clinical Lymphoma Myeloma and Leukemia, 2024

    DOI 10.1016/j.clml.2023.12.015 PMID 38342726 7 atıf (Europe PMC) Kaynak: ORCID

  7. Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_355_22 PMID 37147993 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  8. Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

    Journal of Hematopathology, 2022

    DOI 10.1007/s12308-022-00488-6 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  9. Marjinal Zon Lenfoma Tanılı Hastalarda Klinik Özellikler ve Olası Prognostik Faktörler: İki Merkezden Retrospektif Analiz

    LLM Dergi, 2022

    DOI 10.5578/llm.20229903 Açık erişimli tam metinKaynak: OpenAlex

  10. The impact of hematological parameters on survival for patients with COVID-19

    Ahi Evran Medical Journal, 2022

    DOI 10.46332/aemj.1014259 Açık erişimli tam metinKaynak: OpenAlex

  11. Analysis of Demographic and Disease Characteristics of Patients with Chronic Myeloid Leukemia: A Single Centre Retrospective Analysis

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.08831 Açık erişimli tam metinKaynak: OpenAlex

  12. Does blood type have an effect on the course of COVID-19?

    Sağlık Akademisi Kastamonu, 2022

    DOI 10.25279/sak.1014330 Açık erişimli tam metinKaynak: OpenAlex

  13. Single Centre Experience: Bening and Malign Hematological Patients with COVID-19

    Sağlık Akademisi Kastamonu, 2022

    DOI 10.25279/sak.1061701 Açık erişimli tam metinKaynak: OpenAlex

  14. Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect

    Journal of Clinical Pharmacy and Therapeutics, 2022

    DOI 10.1111/jcpt.13512 PMID 34423448 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  15. Analysis of factors predicting the efficacy of Imatinib in patients with Chronic Myeloid Leukemia: A retrospective analysis

    Medical Science and Discovery, 2022

    DOI 10.36472/msd.v9i9.802 Açık erişimli tam metinKaynak: OpenAlex

  16. THE RELATIONSHIP BETWEEN FERRITIN LEVEL AND THROMBOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

    Hematology Transfusion and Cell Therapy, 2022

    DOI 10.1016/j.htct.2022.09.1244 Açık erişimli tam metinKaynak: OpenAlex

  17. The outcome of COVID-19 in patients with hematological malignancy

    memo - Magazine of European Medical Oncology, 2021

    DOI 10.1007/s12254-021-00775-5 PMID 34904019 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  18. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211007889 PMID 33847196 6 atıf (Europe PMC) Kaynak: OpenAlex

  19. Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211060730 PMID 34775854 3 atıf (Europe PMC) Kaynak: OpenAlex

  20. RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1057 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  21. A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1033 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  22. The Prognostic Value of Blood Count Parameters in Patients with Diffuse Large B Cell Lymphoma

    Akdeniz Medical Journal, 2021

    DOI 10.17954/amj.2021.2566 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  23. A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1034 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  24. Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients

    Gulhane Medical Journal, 2021

    DOI 10.4274/gulhane.galenos.2020.1243 Açık erişimli tam metinKaynak: OpenAlex

  25. A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1045 Açık erişimli tam metinKaynak: OpenAlex

  26. A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1064 Açık erişimli tam metinKaynak: OpenAlex

  27. THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.979 Açık erişimli tam metinKaynak: OpenAlex

  28. T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1019 Açık erişimli tam metinKaynak: OpenAlex

  29. A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1060 Açık erişimli tam metinKaynak: OpenAlex

  30. ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1014 Açık erişimli tam metinKaynak: OpenAlex

  31. INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1018 Açık erişimli tam metinKaynak: OpenAlex

  32. A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1037 Açık erişimli tam metinKaynak: OpenAlex

  33. DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1056 Açık erişimli tam metinKaynak: OpenAlex

  34. COVID-19 ve Kanser

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.668 Kaynak: ORCID

  35. Q fever as a rare cause of hemophagocytic lymphohistiocytosis: Case report

    Transfusion and Apheresis Science, 2020

    DOI 10.1016/j.transci.2020.102747 PMID 32171685 7 atıf (Europe PMC) Kaynak: OpenAlex

  36. Disease and clinical characteristics of patients with chronic myeloproliferative neoplasms: 11-year single center experience

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.077 Açık erişimli tam metinKaynak: OpenAlex

  37. Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.036 Açık erişimli tam metinKaynak: OpenAlex

  38. Saçlı Hücreli Lösemi Tedavisinde Kladribinin Prognoza Etkisi

    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2020

    DOI 10.47572/muskutd.721951 Kaynak: OpenAlex

  39. A rare case: coexistence of small cell lung cancer and chronic lymphocytic leukemia

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.072 Açık erişimli tam metinKaynak: OpenAlex

  40. Localized skin edema associated with ATRA in a patient with acute promyelocytic leukemia: a case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30342-x 1 atıf (OpenAlex) Kaynak: OpenAlex

  41. A rare cause of hemophagocytic lymphohistiocytosis Q fever: a case report

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30374-1 Kaynak: OpenAlex

  42. Clinical features and possible prognostic factors in patients with marginal zone lymphoma: retrospective analysis from two centers

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30277-2 Kaynak: OpenAlex

  43. Richter transformation in patients with chronic lymphocytic leukemia: three cases and literature review

    Leukemia Research, 2019

    DOI 10.1016/s0145-2126(19)30344-3 Kaynak: OpenAlex